News | Archive | 2016

Global Kinetics and uMotif announce technology partnership for Parkinson’s trials
Posted: 2016-12-16 in Press Releases


Brandon Capital to lead Biomedical Translation Fund Consortium - major new Government initiative
Posted: 2016-12-13 in Press Releases


Management Team Strengthened as Auspherix Drives New Class of Antibacterials Towards the Clinic
Posted: 2016-11-17 in Press Releases


Osprey Introduces DyeVert PLUS at TCT
Posted: 2016-11-02 in Press Releases


Osprey Medical Inc. Releases Q3 2016 Cash Flow Results
Posted: 2016-10-14 in Press Releases


Global Kinetics Announces FDA Clearance for its Second Generation Parkinson’s Kinetigraph
Posted: 2016-09-22 in Press Releases


Global Kinetics Corporation Announces New President and CEO
Posted: 2016-08-30 in Press Releases


Osprey Medical Announces Oversubscribed A$28 Million Private Placement
Posted: 2016-08-04 in Press Releases


Osprey Medical Inc.4C Q2 Quarterly Cash Flow Report July '16
Posted: 2016-07-20 in Press Releases


Key Sales Milestones
Posted: 2016-07-07 in Press Releases


Auspherix Appoints Experienced Anti-Infectives Clinician to Scientific Advisory Board
Posted: 2016-07-04 in Press Releases


DyeVert Pilot Trial Results Presented at EuroPCR
Posted: 2016-05-20 in Press Releases


$4m start-up investment to accelerate drug discovery
Posted: 2016-03-23 in Press Releases


Osprey Medical Receives FDA Clearance for Key DyeVert™ System Claims
Posted: 2016-02-08 in Press Releases


Osprey Medical Inc. Quarterly Cash Flow Report
Posted: 2016-01-28 in Press Releases


Auspherix, as part of the BEAM Alliance, Signs Industry Declaration on Beating Antibiotic Resistance
Posted: 2016-01-21 in Press Releases


Brandon Capital Partners Expands into US, Opening Office in San Francisco Bay Area
Posted: 2016-01-08 in Press Releases